BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25239200)

  • 41. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re-irradiation with stereotactic body radiation therapy (SBRT).
    Høyer M
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S15. PubMed ID: 28917253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
    Ren C; Ji T; Liu T; Dang J; Li G
    Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
    Lartigau EF; Tresch E; Thariat J; Graff P; Coche-Dequeant B; Benezery K; Schiappacasse L; Degardin M; Bondiau PY; Peiffert D; Lefebvre JL; Lacornerie T; Kramar A
    Radiother Oncol; 2013 Nov; 109(2):281-5. PubMed ID: 24262821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
    Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
    Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial.
    Deodato F; Macchia G; Cilla S; Ianiro A; Sallustio G; Cammelli S; Buwenge M; Mattiucci GC; Valentini V; Morganti AG
    Br J Radiol; 2019 Feb; 92(1094):20180422. PubMed ID: 30325662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy.
    Ponti E; Lancia A; Ost P; Trippa F; Triggiani L; Detti B; Ingrosso G
    Eur Urol Focus; 2017 Dec; 3(6):538-544. PubMed ID: 28801240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.
    Macchia G; Lazzari R; Colombo N; Laliscia C; Capelli G; D'Agostino GR; Deodato F; Maranzano E; Ippolito E; Ronchi S; Paiar F; Scorsetti M; Cilla S; Ingargiola R; Huscher A; Cerrotta AM; Fodor A; Vicenzi L; Russo D; Borghesi S; Perrucci E; Pignata S; Aristei C; Morganti AG; Scambia G; Valentini V; Jereczek-Fossa BA; Ferrandina G
    Oncologist; 2020 Feb; 25(2):e311-e320. PubMed ID: 32043791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas.
    Verma J; McCutcheon IE; Waguespack SG; Mahajan A
    Pituitary; 2014 Dec; 17(6):539-45. PubMed ID: 24272035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study.
    Aoki M; Hatayama Y; Kawaguchi H; Hirose K; Sato M; Akimoto H; Miura H; Ono S; Takai Y
    J Radiat Res; 2016 Jan; 57(1):55-61. PubMed ID: 26494115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of stereotactic body radiotherapy and stereotactic radiosurgery in the re-irradiation of metastatic spinal tumors.
    Jain AK; Yamada YJ
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1141-52. PubMed ID: 25066490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
    Nantavithya C; Gomez DR; Wei X; Komaki R; Liao Z; Lin SH; Jeter M; Nguyen QN; Li H; Zhang X; Poenisch F; Zhu XR; Balter PA; Feng L; Choi NC; Mohan R; Chang JY
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):558-563. PubMed ID: 29680255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience.
    Rwigema JC; Heron DE; Ferris RL; Gibson M; Quinn A; Yang Y; Ozhasoglu C; Burton S
    Am J Clin Oncol; 2010 Jun; 33(3):286-93. PubMed ID: 19875950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility of stereotactic radiotherapy for lung lesions and conventional radiotherapy for nodal areas in primary lung malignancies.
    Kim YJ; Kim SS; Song SY; Choi EK
    Radiat Oncol; 2018 Jul; 13(1):127. PubMed ID: 29996863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereotactic Body Radiation Therapy With a High Maximum Dose Improves Local Control, Cancer-Specific Death, and Overall Survival in Peripheral Early-Stage Non-Small Cell Lung Cancer.
    Tateishi Y; Takeda A; Horita N; Tsurugai Y; Eriguchi T; Kibe Y; Sanuki N; Kaneko T
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):143-151. PubMed ID: 33891980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
    Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D; Movsas B; Rimner A; Roach M; Rodrigues G; Shirvani SM; Simone CB; Timmerman R; Daly ME
    Pract Radiat Oncol; 2017; 7(5):295-301. PubMed ID: 28596092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.